Credit: CC0 Public Domain Opioids are not among the most effective—or longest lasting—options available for relief from acute dental pain, a new examination of the results from more than 460 published studies has found. Ibuprofen and other nonsteroidal anti-inflammatory drugs (NSAIDs) alone or in combination with acetaminophen are better at easing dental pain, according to […]Continue Reading ...
Credit: CC0 Public Domain Researchers from three universities have found that extreme price competition in the generic pharmaceutical market—designed to make medications more affordable—may be putting more patients at serious health risk, as evidenced by a higher number of product recalls caused by manufacturing-related problems. The same research, published online today in the Journal of […]Continue Reading ...
Inpatient opioid use and insufficient weaning pre-discharge may increase outpatient opioid prescription use. Credit: ATS According to the University of Pittsburgh School of Medicine scientists who conducted the study, theirs is the first large-scale evaluation of the impact of in-hospital opioid prescribing on post-discharge opioid use. “Most previous studies of opioid use in health care […]Continue Reading ...
(HealthDay)—Retacrit (epoetin alfa-epbx) has been approved by the U.S. Food and Drug Administration as the first “biosimilar” to the anemia drugs Epogen and Procrit. A biosimilar, derived from a living organism, has been proven to be “highly similar” to a product that’s already been approved by the FDA. It’s also been shown to have no […]Continue Reading ...
Credit: CC0 Public Domain In a pilot study published in JAMA Internal Medicine, Yale researchers significantly reduced doses of opioid painkillers given to hospital patients. By delivering the opioids with a shot under the skin or with a pill instead of an IV, the research team found they could decrease patient exposure to the medications […]Continue Reading ...
Credit: CC0 Public Domain The opioid crisis continues to weigh heavily on the minds of Americans, according to a new national poll released today by the American Psychiatric Association, (APA). Nearly a third of Americans say they know someone who is or has been addicted to opioids or prescription painkillers. Nearly half feel it is […]Continue Reading ...
In this March 15, 2018 photo, public health nurse Peggy Cooley of the Tacoma-Pierce County Health Department, seen on the phone screen, uses Skype video to remotely monitor a patient taking antibiotics for tuberculosis at home in Lakewood, Wash. Researchers are testing how well smartphone apps that monitor pill-taking work when medication matters. Experts praise […]Continue Reading ...
Credit: CC0 Public Domain Despite the threat of a global health crisis in antibiotic resistance, worldwide use of antibiotics in humans soared 39 percent between 2000 and 2015, fueled by dramatic increases in low-income and middle-income countries (LMICs), according to a new study in the Proceedings of the National Academy of Sciences (PNAS). The study, […]Continue Reading ...
Washington University School of Medicine in St. Louis and Epharmix, a digital health company, have created a new automated text messaging service that may curb opioid abuse and prevent relapse. Patients receive text messages to gauge if they’re feeling OK or struggling with potential relapse. Patients also can activate a panic button to request immediate […]Continue Reading ...
Nicotine, alternate molecular skeletal 2D rendering showing the 3D conformation of its ring at lowest energy in actual space. Credit: Public Domain In a mouse study, a drug that has helped millions of people around the world manage their diabetes might also help people ready to kick their nicotine habits. In a report published this […]Continue Reading ...
The chances of another miracle drug may be waning for Pfizer, as the pharmaceutical giant constrains its research and development budget amid broader cost-cutting efforts It has been 20 years since Viagra was introduced, and Pfizer is still searching for another drug with as much earning power as the revolutionary blue erection pill. If anything, […]Continue Reading ...
Credit: Yale University “It’s not often that a psychiatrist gets to hear ‘Doctor, you saved my life,’ ” said Ellen Edens, M.D., FW ’09, assistant professor of psychiatry and associate fellowship director in addiction psychiatry. But she gets that a lot from patients receiving outpatient treatment for opioid use disorder. “They tell me, ‘I have […]Continue Reading ...
Credit: CC0 Public Domain Giving opioids to animals to quell pain after surgery prolongs pain for more than three weeks and primes specialized immune cells in the spinal cord to be more reactive to pain, according to a new study by the University of Colorado Boulder. The authors say the paradoxical findings, if replicated in […]Continue Reading ...
Harsher drug prohibition won’t stop violence, argue Paul Whitehouse, former Chief Constable of Sussex Police, and Jason Reed at Law Enforcement Action Partnership (LEAP UK) which supports drug policy reform, in The BMJ today. They say spending £40m on policies based on prohibition “is unlikely to solve the problem” and they call for drug policy […]Continue Reading ...
Boston Medical Center (BMC)’s Grayken Center for Addiction is leading a study on the impact of peer recovery coaches on patients with substance use disorder (SUD), including focusing on providing support to patients and helping them achieve sustained recovery. BMC’s Project RECOVER (Referral, Engagement, Case management and Overdose preVention Education in Recovery) will bridge a […]Continue Reading ...
- New study finds increase in use of alternative medicines among children
- Elevated NT-proBNP Found to Up Cardiovascular Risk in T2DM
- Genetics Home Reference: White-Sutton syndrome
- Canadian team reports success in transplanting hepatitis C organs
- Separating migrant children from parents at US border tantamount to child abuse
- Study finds more information about how gene linked to ASD affects the brain
- Floppy eyelids linked to sleep apnea
- Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson
- KIYATEC enrolls first patients with solid tumors in clinical study of its EV3D drug response assay
- Study finds growing support to allow pharmacists to write prescriptions
- Italian innovative SME receives 2.5 million Euro from RedSeed Ventures
- AHA: Kids Can Drown Quickly and Silently, So Prevention Is Key
- Continuous glucose monitors proven cost-effective, add to quality of life for diabetics
- Researchers use droplet-sized ‘miniecosystems’ to test therapeutic potential of molecules
- New approach could provide objective and easy-to-obtain measure of dietary adherence
- Dual-therapy approach can help boost motor recovery in stroke victims
- ‘Miracle treatment’ long-term success for babies with diabetes
- Rheumatoid Arthritis patients with depression have increased risk of disease flare
- NTU launches new research centers to prevent and treat diseases affecting Singaporeans
- Merck enters into agreement with HistoCyte Laboratories to distribute cell line reference products